Browsing by author "Banks E"
Sort by:
Title A-Z
-
The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium
Arriaga ME; Vajdic CM; Canfell K; MacInnis R; Hull P; Magliano D; Banks E; Giles GG; Cumming RG; Byles JE; Taylor AW; Shaw JE; Price K; Hirani V3; Mitchell P; Adelstein BA; Laaksonen MAPublished 2017PURPOSE: To estimate the Australian cancer burden attributable to lifestyle-related risk factors and their combinations using a novel population attributable fraction (PAF) method that accounts for competing risk of death, ...Article -
The burden of pancreatic cancer in Australia attributable to smoking
Arriaga, ME; Vajdic CM; MacInnis RJ; Canfell K; Magliano DJ; Shaw JE; Byles JE; Giles GG; Taylor AW; Gill TK; Hirani V; Cumming RG; Mitchell RP; Banks E; Marker J; Adelstein BA; Laaksonen MAPublished 2019-03Objective To estimate the burden of pancreatic cancer in Australia attributable to modifiable exposures, particularly smoking. Design Prospective pooled cohort study. Setting, participants Seven prospective Australian ...Article -
Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study
Weber MF; Banks E; Smith DP; O'Connell DL; Sitas FPublished 2009ABSTRACT: BACKGROUND: Limited evidence suggests that people from non-English speaking backgrounds in Australia have lower than average rates of participation in cancer screening programs. The objective of this study was ...Article -
The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia
Sitas F; Yap S; Egger S; Christian K; Hodgkinson V; Barton M; Banks E; Canfell K; O'Connell DL; Nair-Shalliker VPublished 2015INTRODUCTION: The New South Wales (NSW) Cancer, Lifestyle and Evaluation of Risk Study (CLEAR) is an open epidemiological bioresource, using an all cancer unmatched case-spouse control design. Participant characteristics ...Article -
Cohort profile: the 45 and up study
Banks E; Cumming R; Harris M; Sitas F; Smith W; Taylor L; Wutzke S; Lujic S; Redman S; Jorm L; Armstrong B; Bauman A; Beard J; Beral V; Byles J; Corbett SPublished 2009Article -
Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
Steffen A; Weber MF; Roder DM; Banks EPublished 2014OBJECTIVE: To investigate the association of colorectal cancer (CRC) screening history and subsequent incidence of CRC in New South Wales, Australia. DESIGN, SETTING AND PARTICIPANTS: A total of 196,464 people from NSW ...Article -
Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study.
Steffen A; Weber MF; Roder DM; Banks EPublished 2014Objective: To investigate the association of colorectal cancer (CRC) screening history and subsequent incidence of CRC in New South Wales, Australia. Design, setting and participants: A total of 196 464 people from NSW ...Article -
Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia
Canfell K; Banks E; Moa AM; Beral VPublished 2008OBJECTIVE: To determine if the recent rapid fall in use of hormone replacement therapy (HRT) in Australia has been followed by a reduction in breast cancer incidence among women aged 50 years or older, but not among younger ...Article -
Early Life UV and Risk of Basal and Squamous Cell Carcinoma in New South Wales, Australia
Kricker A; Weber MF; Sitas F; Banks E; Rahman B; Goumas C; Kabir A; Armstrong BKPublished 2017Sun exposure is the main cause of squamous (SCC) and basal cell carcinoma (BCC) although pattern and amount differ by cancer type, and sun sensitivity is the major host risk factor. Our study investigated risk factors and ...Open AccessArticle -
An Epidemiologicial overview of the relationship between hormone replacement therapy and breast cancer.
Salagame U; Canfell K; Banks EPublished 2011Large-scale randomized clinical trials and observational studies have consistently found thatt use of hormone replacement therapy (HRT) increases the risk of breast cancer. More recently, ecological studies have shown ...Article -
Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality
Smith DP; Banks E; Clements MS; Gardiner RA; Armstrong BKPublished 2009Large-scale randomised controlled trials in Europe and the United States are informing evidence-based clinical adviceArticle -
Factors associated with participation in colorectal cancer screening in Australia: results from the 45 and Up Study cohort
He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell KPublished 2018The Australian Government's National Bowel Cancer Screening Program (NBCSP) was introduced in 2006 to provide free home-based immunochemical faecal occult blood test (iFOBT) to eligible Australians turning 55 and 65 years ...Article -
Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study
Nair-Shalliker V; Bang A; Weber MF; Goldsbury DE; Caruana M; Emery J; Banks E; Canfell K; O'Connell DL; Smith DPPublished 2018Australia has one of the highest incidence rates of prostate cancer (PC) worldwide, due in part to widespread prostate specific antigen (PSA) testing. We aimed to identify factors associated with PSA testing in Australian ...Article -
Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study
Canfell K; Egger S; Velentzis LS; Darlington-Brown J; O'Connell DL; Banks E; Sitas FPublished 2015Background Australia commenced a publically-funded, National Human Papillomavirus (HPV) Vaccination Program in 2007 with a two year catch-up phase for females aged 12–26 years. Objective To identify the factors associated ...Article -
The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohorts
Laaksonen MA; Canfell K; MacInnis R; Arriaga ME; Banks E; Magliano DJ; Giles GC; Cumming RG; Byles JE; Mitchell P; Gill TK; Hirani V; McCullough S; Shaw JE; Taylor AW; Adelstein BA; Vajdic CMPublished 2018BACKGROUND: Knowledge of preventable disease and differences in disease burden can inform public health action to improve health and health equity. We quantified the future lung cancer burden preventable by behavioural ...Open AccessArticle -
Health services costs for cancer care in Australia: Estimates from the 45 and Up Study
Goldsbury DE; Yap S; Weber MF; Veerman L; Rankin N; Banks E; Canfell K; O'Connell DLPublished 2018Background Cancer care represents a substantial and rapidly rising healthcare cost in Australia. Our aim was to provide accurate population-based estimates of the health services cost of cancer care using large-scale linked ...Article -
Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis
Banks E; Reeves GK; Beral V; Balkwill A; Liu B; Roddam APublished 2009BACKGROUND: Bone mineral density is known to decrease rapidly after the menopause. There is limited evidence about the separate contributions of a woman's age, menopausal status and age at menopause to the incidence of hip ...Article -
Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30–44 years: A case-control study in New South Wales, Australia
Xu H; Egger S; Velentzis LS; O'Connell DL; Banks E; Darlington-Brown J; Canfell K; Sitas FPublished 2018Background Human papillomavirus (HPV) vaccines protect against HPV types 16/18, but do not eliminate the need to detect pre-cancerous lesions. Australian women vaccinated as teenage girls are now entering their mid-thirties. ...Open AccessArticle -
HRT and breast cancer: recent findings in the context of the evidence to date
Banks E; Canfell K; Reeves GPublished 2008Article -
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study
Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell KPublished 2014BACKGROUND: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catch-up to the age of 26; catch-up cohorts are thus now entering their thirties. Plans for monitoring vaccine impact involve ...Article
Sort by:
Title A-Z